Rahway, N.J. – Merck, known as MSD outside the United States and Canada, announced the initiation of three new Phase 2b clinical trials to evaluate the safety and efficacy of tulisokibart (MK-7240), an investigational humanized monoclonal antibody designed to target…
The University of Phoenix College of Doctoral Studies has unveiled a new white paper titled “Reinventing Productivity: Aligning AI Innovation with Human Potential in the Modern Workforce.” Authored by Jessica Sylvester, Ed.D., MBA, Senior Manager of College Operations, associate faculty…
Neuraptive Therapeutics, Inc., a biotechnology company developing novel therapies to improve outcomes for patients with peripheral nerve injuries (PNI), announced the enrollment of the first patient in its pivotal Phase 3 clinical trial evaluating NTX-001, a novel therapeutic designed to…
iECURE, Inc., a clinical-stage genome editing company pioneering variant-agnostic in vivo targeted gene insertion therapies for severe liver disorders, announced that new data from the ongoing OTC-HOPE clinical trial evaluating its lead candidate ECUR-506 will be presented at two of…
AliveGen USA Inc. (AliveGen), a clinical-stage biopharmaceutical company focused on developing novel therapies for serious cardiopulmonary diseases, today announced compelling new preclinical results for its investigational therapy ALG-801. The data show that ALG-801 delivered superior efficacy compared with current standard-of-care…
CytoAgents, Inc., a clinical-stage biotechnology company focused on developing safe and effective preventative therapies for life-threatening immune-related toxicities, today announced it has been awarded a $2.25 million grant from the National Institutes of Health (NIH). This grant, issued through the…
Colossal Biosciences, known worldwide as the first and only company dedicated to de-extinction, has reached a groundbreaking milestone. Today, the team celebrates the first birthday of Romulus and Remus—the first living dire wolves in over 12,500 years. Once thought lost…
AI2 Unveils Asta DataVoyager for Scientific Discovery Allen Institute for AI (AI2) is aiming to close this gap. Today, the institute unveiled Asta DataVoyager, a powerful new AI-driven analysis agent within the broader Asta ecosystem. Designed to put intuitive, trustworthy,…